-

$undefined

N/A

(N/A)

DEXCOM INC NASDAQ:DXCM DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.

Location: 6340 Sequence Dr, California, 92121-4356, US | Website: www.dexcom.com | Industry: Surgical and Medical Instrument Manufacturing | Sector: Manufacturing

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

34.71B

Cash

2.579B

Avg Qtr Burn

N/A

Short % of Float

2.54%

Insider Ownership

1.09%

Institutional Own.

96.17%

Qtr Updated

12/31/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date